High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.

Already single time point elevation of sNfL has a distinct effect on brain volume changes over a short-term period, and repeated high levels of sNfL indicate accumulating physical disability. Serial assessment of sNfL may provide added value in the clinical management of pwMS.